COMMUNIQUÉS West-GlobeNewswire

Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
11/09/2026
View the video webcast here SAN DIEGO, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between [...]
Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand
11/09/2026
Fireside chat featuring Bob Jahr, Chief Executive Officer, and H.C. Wainwright Managing Director & Senior Biotechnology Equity Research Analyst Access the video webcast here ISELIN, N.J., Sept. 11, 2026 (GLOBE [...]
Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA
11/09/2026
• Company gains further clarity on the additional information required to advance its PMA review • FDA did not request an additional clinical trial following its 100-day review of the PMA application • Company does not [...]
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
11/09/2026
HOPE is the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared TMS Robotic System; the HOPE clinical team is completing orientation and training at Zeta Surgical's headquarters in Boston [...]
Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
11/09/2026
WILMINGTON, Del., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the H.C [...]
ALK to present at the Morgan Stanley Global Healthcare Conference in New York
11/09/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the company’s Executive Vice President and CFO, Claus Steensen Sølje, is scheduled to participate in a fireside chat at the Morgan Stanley 24th Annual Global [...]
Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)
11/09/2026
Future registration-directed clinical development of efti is intended to focus on head and neck squamous cell carcinoma (HNSCC) in patients with negative PD-L1 expression (Combined Positive Score (CPS) < 1) and the [...]
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
11/09/2026
Vancouver, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen [...]
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
11/09/2026
$2.5 million upfront with up to approximately $5 million of potential aggregate gross proceeds upon the exercise in full of warrants BRISBANE, Calif. , Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. ( [...]
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
11/09/2026
SAN FRANCISCO, CALIFORNIA, Sept. 11, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the [...]
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
11/09/2026
TARPON SPRINGS, Fla., September 11, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated [...]
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
11/09/2026
Access the video webcast here HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that its pre-recorded presentation from the H.C. [...]
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
11/09/2026
NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand [...]
Dental Implant Surgery and Implant Restoration: What Patients Need to Know
11/09/2026
Implant position, depth and angulation are decided during surgery, and the restoration built afterward cannot undo them. Institute for Advanced Dentistry & Implants manages dental implant surgery and implant [...]
Dance Fitness Tempe Announces Expansion of Accessible Digital Movement Programs
11/09/2026
TEMPE, Arizona, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Dance Fitness Tempe today announced the launch of expanded digital dance content and free online workout programs aimed at making movement accessible to its growing [...]
MemoVolt Launch 2026: New Natural Dual-Action Brain and Memory Support Formula Read MemoVolt Brain Supplement Facts & Ingredients Highlights.
11/09/2026
MemoVolt Launch 2026 introduces a natural dual-action brain and memory support formula. Explore MemoVolt Brain Supplement facts, ingredients, and key formulation highlights. New York, Sept. 11, 2026 (GLOBE NEWSWIRE) -- [...]
Accrelist Ltd. Unveils New Vision for Asian Aesthetic Medicine Expansion, A.M Aesthetics Targets 100 Clinics by 2029
11/09/2026
Singapore, Singapore, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Accrelist Ltd. has unveiled a new long-term growth vision for its medical aesthetics brand, A.M Aesthetics , outlining plans to accelerate its expansion across [...]
Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
11/09/2026
Kensington, MD, USA and Munich/Martinsried, Germany, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Kensington, MD, USA, and Munich/Martinsried, Germany, September 11 , 2026 – Galimedix Therapeutics, Inc. (“Galimedix”), a Phase 2 [...]
Mark Holland se joint à la Fondation pour la santé des hommes au Canada à titre de l’un de ses nouveaux membres du conseil d’administration
11/09/2026
VANCOUVER, Colombie-Britannique, 11 sept. 2026 (GLOBE NEWSWIRE) -- L’ancien ministre fédéral de la Santé Mark Holland se joint à l’une des principales organisations canadiennes vouées à la santé des hommes à titre de [...]

Pages